Seyed Mahdi Nassiri
Overview
Explore the profile of Seyed Mahdi Nassiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nassiri S, Ahmadi Afshar N, Almasi P
Stem Cell Res Ther
. 2023 Oct;
14(1):282.
PMID: 37794439
Hematopoiesis is a complex process in which hematopoietic stem cells are differentiated into all mature blood cells (red blood cells, white blood cells, and platelets). Different microRNAs (miRNAs) involve in...
2.
Salari Sedigh H, Saffarpour A, Jamshidi S, Ashouri M, Nassiri S, Dehghan M, et al.
J Oral Biol Craniofac Res
. 2023 Apr;
13(3):403-411.
PMID: 37113531
Objectives: Recent investigations indicate that canine periodontal ligament-derived stem cells (cPDLSCs) may reveal a reliable strategy for repair of periodontal tissues via cell-based tissue engineering approaches Due to limited research,...
3.
Vafaei R, Khaki Z, Salehi M, Jalili N, Esmailinejad M, Muhammadnajad A, et al.
Invest New Drugs
. 2023 Apr;
41(2):226-239.
PMID: 37004643
The usage of monoclonal antibodies (mAbs) and antibody fragments, as a matter associated with the biopharmaceutical industry, is increasingly growing. Harmonious with this concept, we designed an exclusive modeled single-chain...
4.
Abedi M, Marateb H, Mohebian M, Aghaee-Bakhtiari S, Nassiri S, Gheisari Y
Sci Rep
. 2021 Dec;
11(1):23452.
PMID: 34873190
Diabetic nephropathy (DN), the leading cause of end-stage renal disease, has become a massive global health burden. Despite considerable efforts, the underlying mechanisms have not yet been comprehensively understood. In...
5.
Zamani-Ahmadmahmudi M, Nassiri S, Asadabadi A
Sci Rep
. 2021 Oct;
11(1):21098.
PMID: 34702929
Gene expression profiling has been vastly used to extract the genes that can predict the clinical outcome in patients with diverse cancers, including diffuse large B-cell lymphoma (DLBCL). With the...
6.
Ahmadi A, Moghadasali R, Ezzatizadeh V, Taghizadeh Z, Nassiri S, Asghari-Vostikolaee M, et al.
Sci Rep
. 2021 Jul;
11(1):13831.
PMID: 34226599
No abstract available.
7.
Babazadeh S, Nassiri S, Siavashi V, Sahlabadi M, Hajinasrollah M, Zamani-Ahmadmahmudi M
Cell Mol Biol Lett
. 2021 Jun;
26(1):30.
PMID: 34174813
Background: Phenotypic and functional heterogeneity of macrophages is known to be the main reason for their ability to regulate inflammation and promote tumorigenesis. Mesenchymal stem cells (MSCs) are one of...
8.
Moradzadeh K, Nassiri S, Gheisari Y
Res Pharm Sci
. 2020 Jun;
15(2):191-199.
PMID: 32582359
Background And Purpose: Stromal-derived factor (SDF)-1, a chemokine recruiting leucocytes and stem cells, plays an essential role in tissue regeneration. In a previous study, we have unexpectedly found that the...
9.
Zamani-Ahmadmahmudi M, Nassiri S, Soltaninezhad F
Br J Haematol
. 2020 May;
192(2):310-321.
PMID: 32410217
Several prognostic gene signatures have been developed to predict the clinical outcome in patients with multiple myeloma (MM). The most salient disadvantage of the previous signatures is their non-reproducibility in...
10.
Siavashi V, Cheraghi H, Pourmohammad P, Nooshirvani P, Abdolahi S, Solghani A, et al.
Inhal Toxicol
. 2020 Apr;
32(3):131-140.
PMID: 32312128
Sulfur mustard (SM), also known as mustard gas, was first widely used in the Iraq-Iran. After SM exposure, the most prominent clinical signs are the development of extensive non-healing skin...